Continue the same D03 contract-challenge session. Do not restart the review from scratch and do not modify files.

Hard boundaries:
- Work only in the current workspace `.`.
- Read-only review; do not edit any file.
- Do not read real-project or medical-writing paths.
- Runner-managed output path: `runs/codex-subagent_medical_monitoring_r4_d03_contract_challenge_20260811.md`. Do not write it with tools; return the delta review and let the runner persist it.

Read these files only:
- `reviews/medical_monitoring_r4_d03_ip_slice_contract_v1_20260811.md`
- `runs/codex-subagent_medical_monitoring_r4_d03_contract_challenge_20260811.md`

The parent Codex amended `reviews/medical_monitoring_r4_d03_ip_slice_contract_v1_20260811.md`; its current status is `FROZEN_R4_D03_CONTRACT_V1_1` and current SHA-256 is `fa62e2293dd0951c7da76717186ff7d6d8aa3733ee5e1a51804a17c4dd776de9`.

Read only the current revised contract and your prior report at `runs/codex-subagent_medical_monitoring_r4_d03_contract_challenge_20260811.md`. Verify each prior finding F-01 through F-10 against the amended text. For each finding state `CLOSED`, `PARTIAL`, or `OPEN`, cite the exact current contract section/line content, and name any remaining ambiguity that would force implementation to invent semantics.

Also verify that the amended contract still preserves:

- six distinct positive subtypes without formal PD determination;
- actual exposure days distinct from treatment span and from dose count/amount;
- no false inference from one missing row;
- renderer-neutral typed Journey events and stable bidirectional joins;
- sibling not-evaluable coverage gaps without closing another risk.

Return a concise delta review. End with exactly one verdict: `ACCEPT` only if F-01 through F-09 are closed and F-10 is sufficiently specified for implementation/tests; otherwise `REVISE`. Do not claim runtime tests or final product/clinical acceptance.
